Shing‐Hwa Liu

National Taiwan University

Papers

1

Total Citations

38

H-Index

1

About

Shing-Hwa Liu is a leading researcher in surgical oncology and health outcomes, whose work has significantly advanced the understanding of treatment modalities for colorectal cancers. His key research areas encompass comparative effectiveness research, minimally invasive surgery, and health economics, with a particular focus on rectal cancer management. Liu’s major contributions include pioneering population-based studies that rigorously compare open, laparoscopic, and robotic surgical approaches, providing critical evidence on their relative outcomes and costs. His most cited work, a 2017 propensity score matched analysis of nationwide inpatient sample data, has garnered 38 citations and stands as a landmark study in the field, offering the first large-scale, real-world comparison of these techniques. This research has directly informed clinical decision-making and healthcare policy by highlighting the trade-offs between surgical efficacy and financial burden. Liu’s work is notable for its methodological rigor and its impact on bridging the gap between surgical innovation and practical, evidence-based patient care, making him a vital voice in the ongoing evolution of rectal cancer treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of outcome and cost among open, laparoscopic, and robotic surgical treatments for rectal cancer: A propensity score matched analysis of nationwide inpatient sample data
38 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: National Taiwan University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago